Oncoustics has developed machine-learning methods for ultrasound data that allow for the extraction of biomarkers correlated with diseased tissues. Through partnerships with Stanford Radiology and ultrasound device OEM’s, the company’s core technology is initially being developed to screen for liver disease in animals and humans, and has been proven to work in more than 30 peer-review scientific publications.